Interview with Piramal’s Peter DeYoung at DCAT
Key Learning Objectives
- Demonstrate expertise in key areas of drug substance & drug product development and manufacturing with emphasis on APIs and ADCs
- Piramal is expanding to meet current and future market demand
- Piramal is a leader in integrated solutions with 15 sites in NA, EU and India
Recent Videos
Related Content
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025Podcast
In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025Podcast
As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
